A multicenter validation study of sentinel lymph node biopsy by the Japanese Breast Cancer Society

Breast Cancer Research and Treatment

Volumn 63, Issue 1, 2000, Pages 31-40

  Noguchi, Masakuni ^a,b   Motomura, Kazuyoshi ^c   Imoto, Shigeru ^d   Miyauchi, Mitsuru ^e   Sato, Kazuhiko ^f   Iwata, Hiroji ^g   Ohta, Masatoshi ^h   Kurosumi, Masafumi ⁱ   Tsugawa, Koichirou ^b  

^a Operation Center   (Japan)

^b KANAZAWA UNIVERSITY HOSPITAL   (Japan)

^c OSAKA MEDICAL CENTER FOR CANCER AND CARDIOVASCULAR DISEASES   (Japan)

^d NATIONAL CANCER CENTER HOSPITAL EAST   (Japan)

^e CHIBA CANCER CENTER   (Japan)

^f NATIONAL DEFENSE MEDICAL COLLEGE   (Japan)

^g AICHI CANCER CENTER HOSPITAL   (Japan)

^h TOKAI UNIVERSITY TOKYO HOSPITAL   (Japan)

ⁱ SAITAMA CANCER CENTER   (Japan)

Author keywords

Axillary lymph node dissection; Breast cancer; Sentinel lymph node biopsy

Indexed keywords

DISULFINE BLUE; DYE; HUMAN SERUM ALBUMIN TC 99M; INDIGO CARMINE; INDOCYANINE GREEN; TECHNETIUM TIN COLLOID TC 99M;

ADULT; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CLINICAL TRIAL; DIAGNOSTIC ACCURACY; DIAGNOSTIC VALUE; FEMALE; HUMAN; HUMAN TISSUE; LYMPH NODE BIOPSY; LYMPH NODE DISSECTION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MULTICENTER STUDY; PRIORITY JOURNAL; VALIDATION PROCESS;

ADULT; AGED; BIOPSY, NEEDLE; BREAST NEOPLASMS; COLORING AGENTS; DIAGNOSIS, DIFFERENTIAL; FEMALE; HUMANS; LYMPHATIC METASTASIS; MIDDLE AGED; SENSITIVITY AND SPECIFICITY; SENTINEL LYMPH NODE BIOPSY;

EID: 0033787984     PISSN: 01676806     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1006428105579     Document Type: Article

References (50)

1. Total axillary lymphadenectomy in the management of breast cancer
2. The axilla: Not a no-go zone
3. The role of axillary lymph node dissection in breast cancer management
4. Ten-year results of a randomized clinical trial comparing radical mastectomy and total mastectomy with or without radiation
5. Manchester regional breast study - 5 and 10 years results
6. Cancer Research Campaign Work Party: Cancer Research Campaign (King's Cambridge) trial for early breast cancer
7. Risk of lymphedema following the treatment of breast cancer
8. Diagnosis of axillary lymph node metastases in patients with breast cancer
9. Surgical resection and radiolocalization of the sentinel node in breast cancer using a gamma probe
10. Lymphatic mapping and sentinel lymphadenectomy for breast cancer
11. Lymphatic mapping and sentinel node biopsy in the patients with breast cancer
12. An approach for the treatment of penile carcinoma
13. Technical details of intraoperative lymphatic mapping for early stage melanoma
14. Gamma-probe guided localization of lymph nodes
15. Histopathological validation of the sentinel lymph node hypothesis for breast carcinoma
16. Sentinel node biopsy to avoid axillary dissection in breast cancer with clinically negative lymph node
17. Sentinel lymph node mapping in breast cancer
18. Guidelines for sentinel node biopsy and lymphatic mapping of patients with breast cancer
19. Dye-guided sentinel lymphadenectomy in clinically node-negative and node-positive breast cancer patients
20. Sentinel node biopsy in breast cancer with clinically negative lymph-nodes
21. Initial experience with sentinel node biopsy in breast cancer at the National Cancer Center Hospital East
22. Staging efficacy of breast cancer with sentinel lymphadenectomy
23. Efficacy and significance of sentinel lymph node identification with technetium-99m-labeled tin colloids for breast cancer
24. The World Health Organization histological typing of breast tumors
25. Sentinel lymphadenectomy in primary breast carcinoma: An alternative to routine axillary dissection
26. Sentinel lymph node biopsy in breast cancer: Initial experience at Memorial Sloan-Kettering Cancer Center
27. Sentinel lymph node mapping in breast cancer
28. Sentinel lymph node biopsy in breast cancer: Guidelines and pitfalls of lymphoscintigraphy and gamma probe detection
29. Lymphoscintigraphy and feasibility of sentinel node biopsy in 83 patients with primary breast cancer
30. Impact of lymphoscintigraphy on sentinel node identification with Technetium-99m-colloidal albumin in breast cancer
31. Optimized sentinel node scintigraphy in breast cancer
32. Sentinel lymph-adenectomy in breast cancer: Identification of sentinel lymph node and detection of metastases
33. Quantitative lymphoscintigraphy: Basic concepts for optimal uptake of radiocolloids in the parasternal lymph nodes of rabbits
34. Gamma probe guided sentinel node biopsy in breast cancer
35. Development of sentinel node targeting technique in breast cancer patients
36. Extra-axillary sentinel lymph nodes in breast cancer
37. Improved axillary staging of breast cancer with sentinel lymphadenectomy
38. Can sentinel node biopsy avoid axillary dissection in clinically node-negative breast cancer patients?
39. Intraoperative examination of axillary sentinel lymph nodes in breast carcinoma patients
40. Minimally invasive breast carcinoma staging using lymphatic mapping with radiolabelled dextran
41. The sentinel node in breast cancer. A multicenter validation study
42. Comment on 'Improved axillary staging of breast cancer with sentinel lymphadenectomy'
43. Prognosis of breast cancer patients after mastectomy and dissection of internal mammary nodes
44. Internal mammary chain sentinel lymph node identification in breast cancer
45. Inefficacy of internal mammary nodes dissection in breast cancer surgery
46. Lymphoscintigraphy: Radiopharmaceutical selection and methods
47. Consequences of sentinel node in clinical decision making in breast cancer and prospects for future studies
48. Sentinel-node biopsy in breast cancer